| HSBC USA Inc. Market Linked Securities |
 |
| Market Linked Securities –Upside Participation |
| and Contingent Downside |
| Principal at Risk Securities Linked to the Dow Jones Industrial AverageSM |
| Term Sheet to Free Writing Prospectus dated August 4, 2017 |
Summary of Terms
| Issuer | HSBC USA Inc. (“HSBC”) |
| Term | Approximately 5 years |
| Reference Asset | Dow Jones Industrial AverageSM |
| Pricing Date | August 30, 2017* |
| Original Issue Date | September 5, 2017* |
| Principal Amount | $1,000 per security |
| Payment at Maturity per Security | See “How the Payment at Maturity Is Calculated” on page 3 |
| Maturity Date | September 6, 2022* |
| Initial Level | The Official Closing Level of the Reference Asset on the Pricing Date |
| Final Level | The Official Closing Level of the Reference Asset on the Final Valuation Date |
| Reference Return |
Final Level – Initial Level Initial Level |
| Upside Participation Rate | 100% (1.0x) |
| Threshold Level | [55%-60%] of the Initial Level, to be determined on the Pricing Date |
| Final Valuation Date | August 29, 2022* |
| Calculation Agent | HSBC USA Inc., or one of its affiliates |
| Denominations | $1,000 and any integral multiple of $1,000 |
| Agent Discount | Up to 3.75%, of which dealers, including those using the trade name Wells Fargo Advisors (“WFA”), may receive a selling concession of up to 2.50%, and WFA will receive a distribution expense fee of 0.12% |
| CUSIP | 40435FEF0 |
Investment Description
| · | Linked to the Dow Jones Industrial AverageSM |
| · | Unlike ordinary debt securities, the securities do not pay interest or repay a fixed amount of principal at maturity. Instead, the securities provide for a Payment at Maturity that may be greater than, equal to or less than the Principal Amount, depending on the performance of the Reference Asset from its Initial Level to its Final Level. |
The Payment at Maturity will be calculated as follows:
o If the level of the Reference Asset increases from the Initial Level to the Final Level:
You will receive the Principal Amount plus 100% participation in the upside performance of the Reference Asset
o If the level of the Reference Asset does not change, or decreases but the decrease is not more than [40%-45%] (to be determined on the Pricing Date) from the Initial Level to the Final Level:
You will be repaid the Principal Amount (zero return)
o If the level of the Reference Asset decreases by more than [40%-45%] (to be determined on the Pricing Date) from the Initial Level to the Final Level:
You will have full downside exposure to the decrease in the level of the Reference Asset from the Initial Level, and you will lose more than [40%-45%] (to be determined on the Pricing Date), and possibly all, of the Principal Amount.
| · | Investors may lose some, or all, of the Principal Amount |
| · | All payments on the securities are subject to the credit risk of HSBC, and you will have no ability to pursue the issuers of any securities included in the Reference Asset for payment; if HSBC defaults on its obligations, you could lose some or all of your investment |
| · | No periodic interest payments or dividends |
| · | No exchange listing; designed to be held to maturity |
*To the extent that the Issuer makes any change to the expected Pricing Date or expected Original Issue Date, the Final Valuation Date and Maturity Date may also be changed in the Issuer’s discretion to ensure that the term of the securities remains the same.
The Estimated Initial Value of the securities on the Pricing Date is expected to be between $900 and $940 per security, which will be less than the price to public. The market value of the securities at any time will reflect many factors and cannot be predicted with accuracy. The Estimated Initial Value does not represent a minimum price at which we or any of our affiliates would be willing to purchase your securities in the secondary market, if any, at any time. The Estimated Initial Value will be calculated on the Pricing Date and will be set forth in the final pricing supplement. See “Risk Factors — The Estimated Initial Value of the securities, which will be determined by us on the Pricing Date, will be less than the price to public and may differ from the market value of the securities in the secondary market, if any” in the accompanying free writing prospectus.
You should carefully consider, among other things, the matters set forth in “Risk Factors” in this term sheet, beginning on page FWP-8 of the free writing prospectus, page S-1 of the prospectus supplement and page S-2 of the Equity Index Underlying Supplement, as the securities involve risks not associated with conventional debt securities.
This introductory term sheet does not provide all of the information that an investor should consider prior to making an investment decision.
Investors should carefully review the accompanying free writing prospectus, Equity Index Underlying Supplement, prospectus supplement and prospectus before making a decision to invest in the securities. Terms used herein without definition will have the meanings ascribed to them in the accompanying free writing prospectus.
NOT A BANK DEPOSIT AND NOT INSURED OR GUARANTEED BY THE FDIC OR ANY OTHER GOVERNMENTAL AGENCY
Hypothetical Payout Profile
The profile to the right is based on a hypothetical Threshold Level of 57.50% of the Initial Level (the midpoint of the specified Threshold Level range) and the Upside Participation Rate of 100%.
This graph has been prepared for purposes of illustration only. Your actual return will depend on the actual Initial Level, Final Level and Threshold Level, and whether you hold your securities to maturity.
Hypothetical Returns
| Hypothetical Final Level |
Hypothetical Reference Return |
Hypothetical Payment at Maturity |
Hypothetical Return on the Securities |
| 2,000.00 | 100.00% | $2,000.00 | 100.00% |
| 1,800.00 | 80.00% | $1,800.00 | 80.00% |
| 1,600.00 | 60.00% | $1,600.00 | 60.00% |
| 1,400.00 | 40.00% | $1,400.00 | 40.00% |
| 1,200.00 | 20.00% | $1,200.00 | 20.00% |
| 1,100.00 | 10.00% | $1,100.00 | 10.00% |
| 1,040.00 | 4.00% | $1,040.00 | 4.00% |
| 1,020.00 | 2.00% | $1,020.00 | 2.00% |
| 1,000.00(1) | 0.00% | $1,000.00 | 0.00% |
| 980.00 | -2.00% | $1,000.00 | 0.00% |
| 950.00 | -5.00% | $1,000.00 | 0.00% |
| 900.00 | -10.00% | $1,000.00 | 0.00% |
| 800.00 | -20.00% | $1,000.00 | 0.00% |
| 575.00 | -42.50% | $1,000.00 | 0.00% |
| 570.00 | -43.00% | $570.00 | -43.00% |
| 500.00 | -50.00% | $500.00 | -50.00% |
| 400.00 | -60.00% | $400.00 | -60.00% |
| 200.00 | -80.00% | $200.00 | -80.00% |
| 0.00 | -100.00% | $0.00 | -100.00% |
Assumes a hypothetical Threshold Level of 57.50% of the Initial Level (the midpoint of the specified Threshold Level range).
Each security has a Principal Amount of $1,000.
(1) The hypothetical Initial Level. The actual Initial Level will be determined on the Pricing Date.
The above figures are for purposes of illustration only and may have been rounded for ease of analysis. The actual amount you receive on the Maturity Date will depend on the actual Initial Level, Barrier Level and Final Level.
| 2 |
How the Payment at Maturity Is Calculated
On the Maturity Date, for each security you hold, we will pay you the Payment at Maturity, which is an amount in cash, calculated as follows:
| · | If the Final Level is greater than the Initial Level, you will receive a cash payment on the Maturity Date, per $1,000 Principal Amount, equal to: |
$1,000 + ($1,000 x Reference Return x Upside Participation Rate).
| · | If the Final Level is less than or equal to the Initial level but greater than or equal to the Threshold Level, you will receive $1,000 per $1,000 Principal Amount (zero return). |
| · | If the Final Level is less than the Threshold Level, you will receive a cash payment on the Maturity Date, per $1,000 Principal Amount, calculated as follows: |
$1,000 + ($1,000 × Reference Return)
If the Final Level is less than the Threshold Level, you will lose more than [40%-45%] (to be determined on the Pricing Date) , and possibly all, of the Principal Amount.
Dow Jones Industrial AverageSM Daily Closing Levels*
*The graph above sets forth the daily Official Closing Levels of the Reference Asset for the period from January 1, 2008 to August 8, 2017. The historical performance of the Reference Asset is not an indication of its future performance during the term of the securities.
Risk Factors
The risks set forth below are discussed in detail in the “Risk Factors” section in the accompanying free writing prospectus and the accompanying Equity Index Underlying Supplement and prospectus supplement. Please review those risk disclosures carefully.
| · | Your investment in the securities may result in a loss. |
| · | The Reference Return on the securities is not linked to the level of the Reference Asset at any time other than on the Final Valuation Date. |
| · | Credit risk of HSBC USA Inc. |
| · | The securities will not bear interest. |
| · | Changes that affect the Reference Asset may affect the level of the Reference Asset and the market value of the securities and the amount you will receive at maturity. |
| 3 |
| · | The securities are not insured or guaranteed by any governmental agency of the United States or any other jurisdiction. |
| · | The Estimated Initial Value of the securities, which will be determined by us on the Pricing Date, will be less than the price to public and may differ from the market value of the securities in the secondary market, if any. |
| · | The price of your securities in the secondary market, if any, immediately after the Pricing Date may be less than the price to public. |
| · | If an agent were to repurchase your securities immediately after the Original Issue Date, the price you receive may be higher than the Estimated Initial Value of the securities. |
| · | The securities lack liquidity. |
| · | Potential conflicts of interest may exist. |
| · | Historical levels of the Reference Asset should not be taken as an indication of its future performance during the term of the securities. |
| · | The amount you will receive on the securities will depend upon the performance of the Reference Asset. Therefore, the securities are subject to the following risks, as set forth in the accompanying prospectus supplement or the Equity Index Underlying Supplement: |
| o | You must rely on your own evaluation of the merits of an investment in the notes; |
| o | The price at which you will be able to sell your notes prior to maturity will depend on a number of factors, and may be substantially less than the amount you had originally invested; |
| o | The notes are not insured against loss by any third parties; you can depend only on our earnings and assets for payment and interest, if any, on the notes; |
| o | Trading and other transactions by us or our affiliates could affect the trading level or price and/or level of the Reference Asset, the trading value of the notes or the amount you may receive at maturity; |
| o | Research reports and other transactions may create conflicts of interest between you and us; |
| o | Our trading, hedging and other business activities, and those of the agents, may create conflicts of interest with you; |
| o | Equity market risks may affect the trading value of the Notes and the amount due on the Notes; |
| o | As a holder of the Notes, you will not have any ownership interest or rights in the stocks or other securities tracked by an Index |
| o | We or our affiliates are not affiliated with any of the Reference Sponsors; and |
| o | Our or our affiliates business activities relating to the stocks or securities tracked by an equity index may create conflicts of interest with you. |
| · | Uncertain tax treatment. |
Not suitable for all investors
Investment suitability must be determined individually for each investor. The securities described herein are not a suitable investment for all investors. In particular, no investor should purchase the securities unless they understand and are able to bear the associated market, liquidity and yield risks. Unless market conditions and other relevant factors change significantly in your favor, a sale of the securities prior to maturity is likely to result in sale proceeds that are substantially less than the Principal Amount per security. None of HSBC Securities (USA) Inc., Wells Fargo Securities, or their respective affiliates are obligated to purchase the securities from you at any time prior to maturity.
HSBC has filed a registration statement (No. 333-202524) (including a prospectus, prospectus supplement and Equity Index Underlying Supplement) with the Securities and Exchange Commission (the “SEC”) for the offering to which this free writing prospectus relates. Before you invest, you should read the prospectus, prospectus supplement and Equity Index Underlying Supplement in that registration statement and other documents HSBC has filed with the SEC for more complete information about HSBC and this offering. You may get these documents for free by visiting EDGAR on the SEC’s web site at www.sec.gov. Alternatively, HSBC Securities (USA) Inc. or any dealer participating in this offering will arrange to send you the prospectus, prospectus supplement and Equity Index Underlying Supplement if you request them by calling toll-free 1-866-811-8049.
You may access these documents and the free writing prospectus on the SEC web site at www.sec.gov as follows:
The free writing prosectus at: https://www.sec.gov/Archives/edgar/data/83246/000114420417041634/v472444_fwp.htm
The Equity Index Underlying Supplement at: http://www.sec.gov/Archives/edgar/data/83246/000114420415014327/v403626_424b2.htm
The prospectus supplement at: http://www.sec.gov/Archives/edgar/data/83246/000114420415014311/v403645_424b2.htm
The prospectus at: http://www.sec.gov/Archives/edgar/data/83246/000119312515078931/d884345d424b3.htm
Wells Fargo Advisors is a trade name used by Wells Fargo Clearing Services, LLC and Wells Fargo Advisors Financial Network, LLC, members SIPC, separate registered broker-dealers and non-bank affiliates of Wells Fargo & Company.
Consult your tax advisor
Investors should review carefully the accompanying free writing prospectus, Equity Index Underlying Supplement, prospectus supplement and prospectus and consult their tax advisors regarding the application of the U.S. federal tax laws to their particular circumstances, as well as any tax consequences arising under the laws of any state, local or non-U.S. jurisdiction.
| 4 |